Prime Medicine (PRME) Total Liabilities (2021 - 2026)

Prime Medicine has reported Total Liabilities for 6 years, with the latest figure at $218.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 1.45% year-over-year to $218.0 million; the trailing twelve-month figure through Mar 2026 stood at $218.0 million (down 1.45% YoY), and the FY2025 full-year result was $221.9 million, up 53.69% from the prior year.
• Total Liabilities for Q1 2026 stood at $218.0 million, down from $221.9 million in the prior quarter.
• The five-year high for Total Liabilities was $223.2 million in Q3 2025, with the low at $38.1 million in Q1 2023.
• Historically, Total Liabilities has averaged $126.7 million across 5 years, with a median of $143.3 million in 2024.
• Annual changes were most pronounced in 2023 — Total Liabilities slumped 79.1% — and 2025, when it surged 245.63%.
• Prime Medicine's Total Liabilities stood at $44.0 million in 2022, then jumped by 38.0% to $60.8 million in 2023, then jumped by 137.51% to $144.4 million in 2024, then jumped by 53.69% to $221.9 million in 2025, then retreated by 1.73% to $218.0 million in 2026.
• The last three Total Liabilities figures came in at $218.0 million (Q1 2026), $221.9 million (Q4 2025), and $223.2 million (Q3 2025), per Business Quant data.